Preferred Label : Moderate Adverse Event;

NCIt synonyms : Standard Toxicity Grade 2; Grade 2 Moderate Adverse Event;

NCIt related terms : CTCAE Grade 2; 2; Grade 2; MODERATE; Common Terminology Criteria for Adverse Events Grade 2; Toxicity Value 2;

NCIt definition : An experience that is alleviated with simple therapeutic treatments. The event impacts usual daily activities. Includes laboratory test alterations indicating injury, but without long-term risk.;

Alternative definition : CDISC: A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.;

Details


Main resources

You can consult :


https://www.ssmg.be/wp-content/uploads/RMG/407/RMG407_06-13.pdf
2024
Belgium
journal article
CTCAE v4 Grade 2
Moderate Extremity Pain
Borg Category-Ratio 10 Perceived Exertion Score 3
Family Practice
Hyperprolactinemia
Moderate Tumor Infiltrating Lymphocytes
Biomedicine
A Moderate Amount of Effort
Moderate Dysplasia
temperance
Epidermal cGVHD Score 3
general practice
idiopathic hyperprolactinemia
Moderate Response
hyperprolactinemia
Rescinnamine
Moderna
Moderate Level
Fair
Moderate Hallucination
Moderate Adverse Event

---
https://drees.solidarites-sante.gouv.fr/jeux-de-donnees/communique-de-presse/les-formations-aux-professions-de-sante-progression-moderee-du
2023
France
scientific and technical information
A Moderate Amount of Effort
Epidermal cGVHD Score 3
Moderate Extremity Pain
Borg Category-Ratio 10 Perceived Exertion Score 3
Cancer Progression
Moderate Tumor Infiltrating Lymphocytes
During or After
Moderate Response
Number
occupation, nos
temperance
Upon Progression
Moderate Hallucination
Study Subject Enrolled
Moderna
Training
Progression
Moderate Adverse Event
occupations
CTCAE v4 Grade 2
Net
Status Post
Fair
Moderate Dysplasia
Electronic File Format
Moderate Level
Rescinnamine

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.